News for Intec Pharma Ltd (NTEC)

INDP stock touches 52-week low at $0.81 amid market challenges

INDP stock touches 52-week low at $1.02 amid market challenges

INDP stock touches 52-week low at $1.2 amid market challenges

Roy Bingham, CEO of BDSA, anticipates substantial growth in the U.S. cannabis market, projecting sales to reach nearly $46 billion by 2028.

/PRNewswire/ -- According to Coherent Market Insights, the global fibromyalgia treatment market is estimated to be valued at US$ 3,142.4 million in 2022 and is...

Gainers Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) shares climbed 68.1% to close at $58.25 on Tuesday after the company announced that th...

/PRNewswire/ -- Indaptus Therapeutics, Inc. (Nasdaq: INDP) ("Indaptus" or the "Company," and formerly, Intec Parent, Inc.) today announced the closing of its...

Toward the end of trading Friday, the Dow traded down 0.42% to 34,936.96 while the NASDAQ fell 0.75% to 14,667.14. The S&P also fell, dropping...

Midway through trading Friday, the Dow traded down 0.25% to 34,996.01 while the NASDAQ fell 0.62% to 14,686.02. The S&P also fell, dropping 0.45% to ...

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.44%

Midway through trading Monday, the Dow traded down 0.01% to 32,776.65 while the NASDAQ rose 0.31% to 13,361.69. The S&P also fell, dropping 0.04% to ...